Note: the following 16 metabolites were excluded because they were measured in <80% of participants: anserine, 6-phosphogluconate, adenine, anthranilic acid, butyrobetaine, C14:0 CE, C20 carnitine, C54:9 TAG, cholate, glutathione oxidized, glycine, homocysteine, orotate, phosphoenolpyruvate, propionate, and taurodeoxycholate Table S2 . Attenuation of correlation between SAVE scores and top 37 metabolites after further adjustments in addition to age and study site, organized by taxonomy classification Percent attenuation=100*(r1-r2)/r1; where r1=correlation coefficient between SAVE scores and a metabolite adjusting for age and study site, r2=correlation coefficient after further adjustments a For the more commonly measured variables that were not measured in all 287 participants: the correlation coefficient that was further adjusted for that variable was compared to the age-and site-adjusted correlation coefficient restricted to the same sample size to calculate percent attenuation. b Prevalent diseases: cardiovascular diseases, hypertension, diabetes, cancer, peripheral arterial disease, osteoarthritis, depression, and pulmonary diseases c Medications: anti-hypertensives, antilipemics, medications for diabetes, and medications for pulmonary diseases d Current smoking status, body mass index, appendicular lean mass, % fat, daily protein intake, interleukin-6, C-reactive protein, creatinine, cardiovascular disease, cancer, peripheral arterial disease, osteoarthritis, depression, number of prescription medications, anti-hypertensives, antilipemics, medications for diabetes, medications for pulmonary diseases Shading: blue indicates negative attenuation≤-10% (stronger association after adjustment) and red indicates positive attenuation≥10% (weaker association after adjustment) 
